Big Pharma Innovation in Small Places

ven06_a

As more new drugs are bred in little biotechs, executives at giant firms are decamping to startups.

As a vice president of the $38 bil­lion (sales) French drug company Sanofi, Victoria Richon witnessed constant reorganizations that affected her oncology drug development program.

Read more here


Leave a Reply

Your email address will not be published. Required fields are marked *


Home / Cancer Left / Big Pharma Innovation in Small Places